date:Aug 09, 2012
to draw firm conclusions about the effects of the sports drink [Lucozade]Cohen said.
Discussing the Lucozade science in their separate BMJ paper, the Oxford academics objected to what they said were small sample sizes (limiting result applicability), poorly designed research and 'data dredging' (with failure to define outcome measures prior to studies).
Biological outcomes - such as reductions in muscle glycogen use - did not necessarily correlate with improved athletic performance, as claimed